Skip to main content

Table 2 Changes in the treatment during the follow-up

From: Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration

  N (%) Time from MTX onset (months)a JADAS71 at the time of changea
↑MTX dose 18 (32.7) 3.0 (3.0; 6.0) 7.0 (4.5; 11.5)
↓MTX dose 20 (36.4) 7.5 (6.0; 9.0) 0.5 (0.0; 2.5)
Change in route of administration 13 (23.6) 6.0 (4.0; 12.0) 2.0 (0.4; 9.9)
Withdrawal 5 (9.1) 9.0 (8.0; 9.0) 3.0 (0.0; 6.5)
Addition of biologic 14 (25.5) 3.8 (4.0; 8.8) 15.8 (6.5; 13.0)
  1. avalues are medians (interquartile range)